Skip to main content
Premium Trial:

Request an Annual Quote

Hoechst-Ariad Center Teams Up With Harvard, Licenses Pangea Tools

Premium

CAMBRIDGE, Mass.--The Hoechst-Ariad Genomics Center has signed an agreement with the Center for the Preven tion of Cardiovascular Disease of the Harvard School of Public Health to collaborate on the identification of novel genes involved in atherosclerosis and angiogenesis, and to license discoveries from the collaboration.

The center also recently licensed from Pangea Systems proprietary computational algorithms designed to feed accurate molecular information to the center's bioinformatics programs to increase the sensitivity with which molecular targets can be identified and the selectivity with which they can be validated for use in drug discovery. Pangea claimed that its clustering tools allow millions of expressed sequence tags to be rapidly analyzed with unprecedented precision.

Filed under

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.